Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease

This publication has 20 references indexed in Scilit:

• Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage i ovarian clear cell carcinoma
  Gynecologic Oncology, 2003
• Allelotype Analysis of Common Epithelial Ovarian Cancers with Special Reference to Comparison between Clear Cell Adenocarcinoma with Other Histological Types
  Japanese Journal of Cancer Research, 2002
• Clinical characteristics of clear cell carcinoma of the ovary
  Cancer, 2000
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Clear Cell Epithelial Ovarian Cancer (Mesonephroid): Bad Prognosis Only in Early Stages
  Gynecologic Oncology, 1993
• Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma
  Gynecologic Oncology, 1992
• Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic Features
  The American Journal of Surgical Pathology, 1992
• Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.
  Journal of Clinical Oncology, 1991
• Endometrioid and Clear Cell Carcinoma of the Ovary
  International Journal of Gynecological Pathology, 1989
• Clear cell carcinoma of the ovary: A clinicopathologic study with review of the literature
  Cancer, 1981